Use of dextran sulfate
AssigneeTx Medic AB
InventorsBo Nilsson, Olle Korsgren
Life of this patent
Estimating the term…
Abstract
A graft composition intended for transplantation into a human patient comprises an injection solution comprising an isolated therapeutic cell transplant, wherein the therapeutic cell transplant is therapeutic to a human patient, and dextran sulfate, or a pharmaceutically acceptable salt thereof, having an average molecular weight of less than 20,000 Da.
Claims17
A graft composition intended for transplantation into a human patient, comprising an injection solution which is pharmaceutically acceptable for human injection and which comprises an isolated therapeutic cell transplant, wherein the therapeutic cell transplant is therapeutic to a human patient and comprises cells selected from the group consisting of insulin-producing beta-cells and embryonic xenogeneic neural cells, and dextran sulfate, or a pharmaceutically acceptable salt thereof, having an average molecular weight of less than 20,000 Da.
Dependencies are inferred from the claim text.